Australian Health Regulator Issues Warning Over Counterfeit Weight Loss Drugs
The Therapeutic Goods Administration (TGA), Australia’s national health regulator, has issued an urgent safety warning following a serious medical incident. An individual was recently hospitalised with a torn oesophagus after using a product they believed was the experimental weight loss drug, retatrutide.
Health officials discovered that the substance the person consumed was actually a counterfeit product. This means the drug was not manufactured or tested by legitimate pharmaceutical companies, making it extremely dangerous for human use. The patient suffered severe internal injuries, highlighting the significant risks associated with purchasing unverified medications online.
Retatrutide is currently an experimental drug and is not yet approved for public use in Australia. The TGA warns that many websites claim to sell these types of weight loss treatments, but these products often contain unknown ingredients or incorrect dosages. These unregulated substances can lead to life-threatening health complications, including organ damage and severe allergic reactions.
Medical experts are urging Australians to avoid buying prescription medications from unofficial sources or websites that do not require a doctor’s prescription. If a person is interested in weight loss treatments, they should consult a registered general practitioner to discuss safe and legal options.
The TGA continues to investigate the source of the counterfeit product. They are reminding the public that if a deal for a weight loss drug seems too good to be true, or if the medication is being sold without a prescription, it is likely unsafe and should be avoided.